• Home
  • Study Details
By physician referral or invitation only

Metastatic breast cancer biomarker study

The purpose of this study is to learn more about how metastatic breast cancer changes over time and how those changes may affect which treatments work best. By studying tumor tissue and blood samples, researchers hope to identify specific features, called biomarkers, that can help match each person to the treatment that's most likely to help them. This information may also help doctors better understand why some cancers respond to treatment and others do not, so that future patients can receive more personalized care.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Lisa Carey
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Breast)

IRB Number

25-2830

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research